SCHEMBL44546

SCHEMBL44546

[CH2]CCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233400 0.96 DNM1 (0.61)
SCHEMBL4755739 0.96 DNM1 (0.61)
SCHEMBL4755756 0.96 DNM1 (0.61)
SCHEMBL2796068 0.96 DNM1 (0.61)
SCHEMBL2031871 0.96 DNM1 (0.61)
SCHEMBL2796425 0.96 DNM1 (0.61)
SCHEMBL4754026 0.96 DNM1 (0.61)
SCHEMBL5085490 0.96 DNM1 (0.61)
SCHEMBL3054555 0.96 DNM1 (0.61)
SCHEMBL233652 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8568 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119776840-A Environment-friendly water-based efficient antirust agent and preparation method and application thereof 南京凯时通新材料有限公司 2025-04-08 CN claimed
US-20240216490-A1 Autoantigens Engineered to Suppress Autoimmune Response ADAXION THERAPEUTICS, INC. 2024-07-04 US claimed
EP-4392077-A2 TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2 (TACSTD2) ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF R.P. Scherer Technologies, LLC (US) 2024-07-03 EP claimed
EP-4392456-A2 ANTIBODIES HAVING HUMANIZED FRAMEWORK REGIONS R.P. Scherer Technologies, LLC (US) 2024-07-03 EP claimed
US-20240197907-A1 Dual-Cleavage Ester Linkers for Antibody-Drug Conjugates ARES CAPITAL CORPORATION, AS COLLATERAL AGENT 2024-06-20 US claimed
EP-4377320-A2 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF R.P. Scherer Technologies, LLC (US) 2024-06-05 EP claimed
US-20240166693-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 Design Therapeutics, Inc. 2024-05-23 US claimed
US-20240158439-A1 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY PROVID PHARMACEUTICALS INC. 2024-05-16 US claimed
US-11980668-B2 Sulfatase-cleavable linkers for antibody-drug conjugates R.P. SCHERER TECHNOLOGIES, LLC (US) 2024-05-14 US claimed
US-20240148883-A1 Branched Linkers for Antibody-Drug Conjugates and Methods of Use Thereof ARES CAPITAL CORPORATION, AS COLLATERAL AGENT 2024-05-09 US claimed
US-4293485-A PEPTIDE FUNGICIDE ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
US-4293487-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
US-4293488-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
US-4293491-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
EP-0032009-A1 Derivatives of cyclic peptide nuclei ELI LILLY AND COMPANY (US) 1981-07-15 EP claimed
EP-0031104-A1 Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them SANTEN PHARMACEUTICAL CO., LTD. (JP) 1981-07-01 EP claimed
US-4271269-A Regeneration of an enzyme immobilizate DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) 1981-06-02 US claimed
US-4183920-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1980-01-15 US claimed
US-4124756-A REACTION WITH PROTECTED AMINO ACIDS TO FORM 3-DE-O-METHYL-N-ACYLFORTIMICINS; ANTIBACTERIAL ABBOTT LABORATORIES (US) 1978-11-07 US claimed
US-3983046-A Functional fluid compositions containing epoxy additives MCDONNELL DOUGLAS CORPORATION (US) 1976-09-28 US claimed